Nuclea Biotechnologies Acquires Manufacturing Company

By Andy McKeeveriBerkshires Staff
Print Story | Email Story

PITTSFIELD, Mass. — Nuclea Biotechnologies will now be able to manufacture and sell its products with the purchase of a Cambridge company.

Nuclea has reached a $5 million deal to purchase Wilex Inc., the United States subsidiary of the German Wilex AG, and take control of a 20,000 square-foot facility and 11 employees, with the expectation of hiring seven more. The move turns Nuclea from strictly development to commercialization.

"This brings Nuclea to fully commercial," CEO Pat Muraca said on Friday. "We are now able to manufacture our own products where before we had to use third-party manufacturers to do most of the work."

Nuclea specializes in developing pharmaceutical and diagnostic procedures for the medical industry. Its clients include Boston Medical Center and the Dana Farber Institute.

The Pittsfield-based Nuclea will now inherit a $2.5 million loan the subsidiary had with the parent company as well as provide $2.5 million in work to develop a new product for Wilex AG.

"We are inheriting the debt guaranteed from Wilex AG," Muraca said.

Wilex Inc. already has two products in the marketplace that will provide ongoing revenue for Nuclea and streamlines the company's ability to get new products on the market.


"This is accelerated growth for Nuclea," Muraca said. "It is the next milestone... it allows us to put our products into he market."

Muraca said the purchase came together in about 10 weeks. In March, the two companies hashed out a licensing agreement for access to one of the company's products and the two had a "synergy." The deal was complicated, Muraca said, but "is really good for Nuclea."

"We will pick up all operational expenses, 11 employees and a 20,000 square-foot manufacturing facility," Muraca said. "This is a state-of-the-art facility in Cambridge."

The additional seven employees will be added to sell the products, he said. While the Cambridge facility is "state of the art," Muraca said he will be looking at moving the manufacturing to Pittsfield if and when a life science center is built at the William Stanley Business Park, which is overseen by the Pittsfield Economic Development Authority.

"If life sciences really takes off at PEDA, then it is a real possibility that we can move the facility here," he said.

Last year,  the company's headquarters moved into a 1,700 square-foot office in the William Stanley Business Park and launched a collaboration with Berkshire Community College and the Massachusetts College of Liberal Arts to create the pipeline of employees for a life science industry. The company also has operations in Worcester.

Nuclea has developed and is commercializing unique diagnostic tests for colon, breast, leukaemia, lung and prostate cancer.


Tags: business park,   cancer research,   expansion,   life sciences,   PEDA,   

If you would like to contribute information on this article, contact us at info@iberkshires.com.

District Moving On From Allegations Against PHS Administrator

By Brittany PolitoiBerkshires Staff

PITTSFIELD, Mass. — The district is "moving on" from unsubstantiated allegations against two Pittsfield High School administrators, saying there is no threat.

Dean of Students Molly West returned to work last week after being put on leave in December. The Department of Children and Families has cleared West and Vice Principal Alison Shepard of misconduct claims that surfaced after another PHS dean was arrested and charged by the U.S. Attorney's Office for allegedly conspiring to traffic large quantities of cocaine.

School Committee Chair William Cameron on Wednesday emphasized that when such an investigation finds no evidence of wrongdoing, fundamental fairness and due process prohibits taking punitive action simply because of allegations. Reportedly, West was also investigated and cleared in the past.

"The circumstances of Mrs. West being placed on administrative leave don't need to be recited here," he said.

"Social media allegations made against her in December, which then regrettably were widely publicized, were not new. They had been heard, investigated, and found meritless by other school districts many years ago, nevertheless, they were disinterred recently by someone providing neither evidence nor a credible source and then reinvestigated twice in the last three months."

Senior Emma Goetze said she was "appalled, deeply disappointed, and frustrated that an administrator who has been placed on leave, someone who has caused significant discomfort and distress to so many students, has been allowed to return to our building."

"I understand that there is an investigation and acknowledge that this individual was cleared but it feels incredibly unjust to me and to many of my peers that despite everything, this person is being given the opportunity to come back," she said. "It's important to recognize that even though an investigation may have found no wrongdoing, that doesn't change the reality of how this individual's presence makes many students feel."

Investigations led by DCF and retired Superior Court Judge Mary-Lou Rup concluded that there is no evidence to substantiate the accusations.

View Full Story

More Pittsfield Stories